This page includes information about Coronavirus Disease 2019 (COVID-19) for travelers and travel-related industries.
Learn more about the recommendation for masks on public transportation and transportation hubs to prevent the spread of COVID-19.
Communication Resources for Travelers regarding travel health alerts and COVID-19.
People of Any Age with Underlying Medical Conditions
This registry collects health information from pregnant people who get vaccinated. This helps to expand vaccine safety data to further ensure vaccine safety.
Other diagnostic tests for SARS-CoV-2
From 20 to 22 April, MediPIET fellows participated in their first face-to-face training activity – the Project Review Module.
This document focuses on communication strategies for case interviews and provides suggested language for case investigators as they cover each topic area during an interview.
CDC is using both new and existing information technology (IT) systems to rapidly collect reliable data about how many doses of COVID-19 vaccines have been delivered (distribution) and how many people have been vaccinated with those doses (administration)
This page provides a broad overview of therapies that are currently recommended for COVID-19 treatment. The FDA can issue emergency use authorizations (EUAs) to allow healthcare providers to use products that are not yet approved, or are approved for other uses, to treat patients with COVID-19 if certain legal requirements are met. The National Institutes of Health (NIH) has developed and regularly updates Treatment Guidelines to help guide healthcare providers caring patients with COVID-19. Any treatments that are used for COVID-19 should be under the care of a healthcare provider.
Globally, health systems have been challenged by the overwhelming demands of the COVID-19 pandemic. Resources and staff are being diverted to test and treat people with presumed or diagnosed COVID-19, and supplies are limited. Some healthcare services are being compromised in order to meet the demands of caring for COVID-19 patients, and many people fear accessing healthcare facilities due to fear of acquiring the virus.
Find links to resources for clinicians caring for patients with a suspected or confirmed infection caused by coronavirus disease 2019 (COVID-19).
Formula milk companies are paying social media platforms and influencers to gain direct access to pregnant women and mothers at some of the most vulnerable moments in their lives. The global formula milk industry, valued at some US$ 55 billion, is targeting new mothers with personalized social media content that is often not recognizable as advertising.
Categories: World Health Organization
An increase in severe acute hepatitis cases of unknown aetiology among previously healthy children was first reported by the United Kingdom (UK) to the World Health Organization’s International Health Regulations (IHR) notification system on 5 April 2022 (testing had excluded viral hepatitis types A, B, C, D and E and other known causes of acute hepatitis). Following this alert, the United States and several European Union, European Economic Area (EU/EEA) and other countries have reported suspected cases.
ECDC publishes Rapid Risk Assessment - Increase in severe acute hepatitis cases of unknown aetiology in children
Following the initial report of an increase of severe acute hepatitis cases of unknown aetiology among previously healthy children by the United Kingdom on 5 April 2022, and as of 20 April 2022, 111 cases, aged 10 and under have been identified in that country.
A second booster could avert a substantial proportion of COVID-19 deaths between now and mid-autumn 2022 in older age groups
A continuous high incidence or a large surge in cases in the early summer would imply a large benefit from an early second booster roll-out but optimal timing will largely depend on trends in infections ECDC says in the latest technical report on a second mRNA COVID-19 vaccine booster dose.